The adjustment in price target by a reputable analyst like Daniel Ives could have a mixed impact. While maintaining an Outperform rating indicates a positive outlook on the company, the reduction in price target might cause short-term concern among investors, potentially leading to a neutral impact on the stock price in the short term.